| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-19 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-19 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-17 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-16 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-15 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-15 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-12 |